Nasim Ebrahimi Selected Research

Nasim Ebrahimi Research Topics

18	Neoplasms (Cancer) 02/2024 - 01/2021
3	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2022
3	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2022
2	Autoimmune Diseases (Autoimmune Disease) 02/2024 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 02/2023 - 01/2022
2	Carcinogenesis 01/2023 - 10/2022
2	Infections 12/2021 - 01/2021
1	Diarrhea 12/2023
1	Bacillary Dysentery (Shigellosis) 12/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Rheumatoid Arthritis 01/2022
1	Multiple Sclerosis 01/2022
1	Inflammation (Inflammations) 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Retinoblastoma (Glioblastoma, Retinal) 12/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2021
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2020
1	Meningitis 10/2014

6	Proteins (Proteins, Gene)FDA Link 02/2024 - 12/2021
6	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2021
3	Long Noncoding RNAIBA 10/2022 - 01/2022
2	VaccinesIBA 01/2022 - 12/2021
1	AntibodiesIBA 02/2024
1	Epidermal Growth Factor (EGF)IBA 01/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2023
1	Small Interfering RNA (siRNA)IBA 12/2023
1	MicroRNAs (MicroRNA)IBA 10/2023
1	Phosphotransferases (Kinase)IBA 03/2023
1	tyrosine receptor (receptor, tyrosine)IBA 03/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2023
1	CannabinoidsIBA 01/2023
1	EndocannabinoidsIBA 01/2023
1	LipidsIBA 10/2022
1	Nucleic AcidsIBA 10/2022
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 10/2022
1	GTP Phosphohydrolases (GTPases)IBA 10/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	AutoantigensIBA 01/2022
1	AntigensIBA 01/2022
1	Cancer VaccinesIBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 12/2021
1	SteroidsIBA 01/2020
1	Colistin (Coly-Mycin)FDA Link 10/2014

10	Therapeutics 12/2023 - 01/2021
3	Immunotherapy 02/2024 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2024 - 03/2023
1	Combination Drug Therapy (Combination Chemotherapy) 03/2023
1	Oncolytic Virotherapy 01/2021